Prognostic impact of HNF4α expression in TTF-1-negative non-squamous NSCLC treated with immune checkpoint inhibitor
HNF4α expression in TTF-1-negative non-Sq NSCLC was associated with worse prognosis in patients treated with ICI.
Authors
- Ryo Ariyasu (ORCID: https://orcid.org/0000-0003-4393-9176)
- Mayu Sugai (ORCID: https://orcid.org/0000-0003-2801-2196)
- Noriko Yanagitani
- Hirokazu Iso (ORCID: https://orcid.org/0000-0002-3672-679X)
- Yoshiaki Amino
- Masahiro Ito
- Hironori Ninomiya (ORCID: https://orcid.org/0009-0004-6814-8471)
- Masahiro Seike (ORCID: https://orcid.org/0000-0002-1572-5472)
- Ryosuke Tsugitomi
- Syunsuke Fujishima
- Makoto Nishio (ORCID: https://orcid.org/0000-0003-4969-4165)
- Ken Uchibori (ORCID: https://orcid.org/0000-0003-1491-923X)
- K. Nibuya
Institutions
- The Cancer Institute Hospital (JP)
- Japanese Foundation For Cancer Research (JP)
- Nippon Medical School (JP)
Publication Details
- Journal
- Lung Cancer
- Published
- 2025-06-19
- DOI
- https://doi.org/10.1016/j.lungcan.2025.108631
- Primary Topic
- Gastrointestinal Tumor Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00